Generic semaglutide India - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Booz Allen Hamilton (NYSE: BAH) unveils five-product Vellox cyber platform at RSAC 2026 with autonomous remediation at its core

Representative image of AI-driven browser security monitoring dashboards as Neon Cyber partners with SpyCloud to deliver real-time breach intelligence and credential exposure alerts, helping enterprises detect compromised identities faster and prevent account takeover attacks.

Neon Cyber teams with SpyCloud to bring real-time breach intelligence to browser security

IntraBio’s AQNEURSA sNDA submission to the FDA for Ataxia-Telangiectasia signals a potential first-ever treatment breakthrough for the rare neurodegenerative disorder—representative image.

IntraBio files first-ever FDA application for an Ataxia-Telangiectasia drug with AQNEURSA sNDA submission

Representative image of Permian Basin natural gas compression infrastructure as Kodiak Gas Services (NYSE: KGS) expands footprint with $24m compression asset acquisition and 7-year service contract.

Kodiak Gas Services (NYSE: KGS) closes $24m Permian Basin compression deal with 7-year service contract

Read More

9 minute read

Pharma Industry News

NATCO Pharma (NSE: NATCOPHARM) launches cheapest semaglutide in India at Rs 1,290 on Day 1 of patent expiry

NATCO Pharma launches generic semaglutide in India at INR 1,290 on Day 1 of patent expiry. What it means for GLP-1 markets. Read the full analysis.

March 20, 2026

web analytics